Product NDC: | 0517-0830 |
Proprietary Name: | Latanoprost |
Non Proprietary Name: | Latanoprost |
Active Ingredient(s): | 50 ug/mL & nbsp; Latanoprost |
Administration Route(s): | OPHTHALMIC |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0517-0830 |
Labeler Name: | American Regent, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200925 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110802 |
Package NDC: | 0517-0830-01 |
Package Description: | 1 BOTTLE, PLASTIC in 1 CARTON (0517-0830-01) > 2.5 mL in 1 BOTTLE, PLASTIC |
NDC Code | 0517-0830-01 |
Proprietary Name | Latanoprost |
Package Description | 1 BOTTLE, PLASTIC in 1 CARTON (0517-0830-01) > 2.5 mL in 1 BOTTLE, PLASTIC |
Product NDC | 0517-0830 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Latanoprost |
Dosage Form Name | SOLUTION |
Route Name | OPHTHALMIC |
Start Marketing Date | 20110802 |
Marketing Category Name | ANDA |
Labeler Name | American Regent, Inc. |
Substance Name | LATANOPROST |
Strength Number | 50 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient] |